Literature DB >> 12140288

Three different binding sites of Cks1 are required for p27-ubiquitin ligation.

Danielle Sitry1, Markus A Seeliger, Tun K Ko, Dvora Ganoth, Sadie E Breward, Laura S Itzhaki, Michele Pagano, Avram Hershko.   

Abstract

Previous studies have shown that the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) is targeted for degradation by an SCF(Skp2) ubiquitin ligase complex and that this process requires Cks1, a member of the highly conserved Suc1/Cks family of cell cycle regulatory proteins. All proteins of this family have Cdk-binding and anion-binding sites, but only mammalian Cks1 binds to Skp2 and promotes the association of Skp2 with p27 phosphorylated on Thr-187. The molecular mechanisms by which Cks1 promotes the interaction of the Skp2 ubiquitin ligase subunit to p27 remained obscure. Here we show that the Skp2-binding site of Cks1 is located on a region including the alpha2- and alpha1-helices and their immediate vicinity, well separated from the other two binding sites. All three binding sites of Cks1 are required for p27-ubiquitin ligation and for the association of Skp2 with Cdk-bound, Thr-187-phosphorylated p27. Cks1 and Skp2 mutually promote the binding of each other to a peptide similar to the 19 C-terminal amino acids of p27 containing phosphorylated Thr-187. This latter process requires the Skp2- and anion-binding sites of Cks1, but not its Cdk-binding site. It is proposed that the Skp2-Cks1 complex binds initially to the C-terminal region of phosphorylated p27 in a process promoted by the anion-binding site of Cks1. The interaction of Skp2 with the substrate is further strengthened by the association of the Cdk-binding site of Cks1 with Cdk2/cyclin E, to which phosphorylated p27 is bound.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140288     DOI: 10.1074/jbc.M205254200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase.

Authors:  Kui Xu; Charles Belunis; Wei Chu; David Weber; Frank Podlaski; Kuo-Sen Huang; Steven I Reed; Lyubomir T Vassilev
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

2.  Noncatalytic requirement for cyclin A-cdk2 in p27 turnover.

Authors:  Xin-Hua Zhu; Hoang Nguyen; H Dorota Halicka; Frank Traganos; Andrew Koff
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  Direct role for proliferating cell nuclear antigen in substrate recognition by the E3 ubiquitin ligase CRL4Cdt2.

Authors:  Courtney G Havens; Nadia Shobnam; Estrella Guarino; Richard C Centore; Lee Zou; Stephen E Kearsey; Johannes C Walter
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

4.  Overexpression of Cks1 is associated with poor survival by inhibiting apoptosis in breast cancer.

Authors:  Xiao-Chun Wang; Li-Li Tian; Jing Tian; Hai-Liang Wu; Ai-Min Meng
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-08       Impact factor: 4.553

5.  Cyclin-dependent kinase regulatory subunit 1 promotes cell proliferation by insulin regulation.

Authors:  Chun-Yan Liu; Wen-Li Zhao; Jin-Xing Wang; Xiao-Fan Zhao
Journal:  Cell Cycle       Date:  2015-07-22       Impact factor: 4.534

6.  Flipping the switch from g1 to s phase with e3 ubiquitin ligases.

Authors:  Lindsay F Rizzardi; Jeanette Gowen Cook
Journal:  Genes Cancer       Date:  2012-11

7.  Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.

Authors:  Shojiro Kitajima; Yasusei Kudo; Ikuko Ogawa; Tarig Bashir; Masae Kitagawa; Mutsumi Miyauchi; Michele Pagano; Takashi Takata
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1.

Authors:  Dana Ungermannova; Junglim Lee; Gan Zhang; H Garry Dallmann; Charles S McHenry; Xuedong Liu
Journal:  J Biomol Screen       Date:  2013-04-15

9.  Impact of siRNA targeting pirh2 on proliferation and cell cycle control of the lung adenocarcinoma cell line A549.

Authors:  Yuan Su; Liping Zhu; Yang Jin; Xiaoju Zhang; Qiong Zhou; Ming Bai
Journal:  Front Med China       Date:  2007-10-01

10.  Information theoretical quantification of cooperativity in signalling complexes.

Authors:  Tom Lenaerts; Jesper Ferkinghoff-Borg; Joost Schymkowitz; Frederic Rousseau
Journal:  BMC Syst Biol       Date:  2009-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.